PlainRecalls
FDA Drug Low Class III Terminated

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.

Reported: August 3, 2016 Initiated: May 18, 2016 #D-1449-2016

Product Description

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.

Reason for Recall

Failed Tablet/Capsule Specifications

Details

Recalling Firm
Teva North America
Units Affected
14, 370 units
Distribution
Nationwide and Puerto Rico
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.. Recalled by Teva North America. Units affected: 14, 370 units.
Why was this product recalled?
Failed Tablet/Capsule Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on August 3, 2016. Severity: Low. Recall number: D-1449-2016.